More than $75B in branded drugs will have gone generic from 2005-2008. CNBC's Mike Huckman discusses the generic pharma industry with Robert Coury, Mylan Laboratories CEO.
Topics:
Pharmaceuticals | Biotechnology
COMMENTS
Thank you for joining our discussion. Your comment has been posted.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT